Northwest Biotherapeutics reported $494K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agenus USD 33.7M 500K Mar/2026
AstraZeneca USD 15.38B 90M Jun/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Celldex Therapeutics USD 22K 7K Jun/2026
Eisai JPY 234.33B 28.9B Jun/2026
Merck USD 16.6B 310M Jun/2026
Northwest Biotherapeutics USD 494K 294K Mar/2026
Pfizer USD 15.03B 530M Jun/2026
Plus Therapeutics USD 1.03M 339K Mar/2026
Roche Holding CHF 30.36B 14.71B Jun/2026